表紙
市場調查報告書
商品編碼
1028944

嗜中性白血球低下症生物製藥的全球市場:COVID-19的成長及變化預測 (∼2030年)

Neutropenia Biologic Drug Treatment Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球嗜中性白血球低下症生物製藥的市場調查,彙整市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的轉變·預測,藥物類型·治療類型·通路·地區/主要國家等各種區分的明細,競爭環境,主要企業的簡介,未來展望等資料。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場趨勢·市場策略

第4章 COVID-19的影響

第5章 市場規模·成長預測

  • 市場規模的轉變·預測
  • 市場成長的促進因素
  • 市場阻礙成長要素

第6章 市場分析·預測:各種區分

  • 各藥物類型
    • Filgrastim
    • Pegfilgrastim
    • Lenograstim
    • Lipegfilgrastim
    • Sargramostim
  • 各治療類型
    • 抗生素
    • 顆粒細胞增生因子(G-CSF)
    • 抗真菌藥物
    • 其他
  • 各銷售管道
    • 零售藥局
    • 醫院藥局
    • 線上藥局

第7章 市場分析·預測:各地各國

第8章 亞太地區市場分析·預測

  • 市場概要
  • 地區資訊·COVID-19的影響·市場資訊·背景資訊·政府措施·法律規章·機關&協會·租稅·投資·主要企業
  • 市場分析·預測:各藥物類型
  • 市場分析·預測:各治療類型

第9章 中國市場分析·預測

第10章 印度市場分析·預測

第11章 日本市場分析·預測

第12章 澳洲市場分析·預測

第13章 印尼市場分析·預測

第14章 韓國市場分析·預測

第15章 西歐市場分析·預測

第16章 英國市場分析·預測

第17章 德國市場分析·預測

第18章 法國市場分析·預測

第19章 東歐市場分析·預測

第20章 俄羅斯市場分析·預測

第21章 北美市場分析·預測

第22章 美國市場分析·預測

第23章 南美市場分析·預測

第24章 巴西市場分析·預測

第25章 中東市場分析·預測

第26章 非洲市場分析·預測

第27章 競爭情形·企業簡介

  • 競爭情形
  • 企業簡介
    • Teva Pharmaceutical
    • Amgen
    • Sanofi
    • Mylan
    • Kyowa Kirin

第28章 開發平台分析

第28章 主要M&A

第29章 未來展望·潛在性分析

第30章 附錄

目錄
Product Code: h969

Neutropenia Biologic Drug Treatment Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global neutropenia biologic drug treatment market.

This report focuses on neutropenia biologic drug treatment market which is experiencing strong growth. The report gives a guide to the neutropenia biologic drug treatment market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the neutropenia biologic drug treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Neutropenia Biologic Drug Treatment market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider neutropenia biologic drug treatment market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The neutropenia biologic drug treatment market section of the report gives context. It compares the neutropenia biologic drug treatment market with other segments of the neutropenia biologic drug treatment market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, neutropenia biologic drug treatment indicators comparison.

Scope

Markets Covered:

1) By Drug Type: Filgrastim; Pegfilgrastim; Lenograstim; Lipegfilgrastim; Sargramostim

2) By Treatment Type: Antibiotic Drugs; Granulocyte-Colony-Stimulating Factor (G-CSF); Antifungal Drugs; Others

3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Pharmacies

Companies Mentioned: Teva Pharmaceutical; Amgen; Sanofi; Mylan; Kyowa Kirin

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Neutropenia Biologic Drug Treatment Market Characteristics

3. Neutropenia Biologic Drug Treatment Market Trends And Strategies

4. Impact Of COVID-19 On Neutropenia Biologic Drug Treatment

5. Neutropenia Biologic Drug Treatment Market Size And Growth

  • 5.1. Global Neutropenia Biologic Drug Treatment Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Neutropenia Biologic Drug Treatment Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Neutropenia Biologic Drug Treatment Market Segmentation

  • 6.1. Global Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Filgrastim
  • Pegfilgrastim
  • Lenograstim
  • Lipegfilgrastim
  • Sargramostim
  • 6.2. Global Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Antibiotic Drugs
  • Granulocyte-Colony-Stimulating Factor (G-CSF)
  • Antifungal Drugs
  • Others
  • 6.3. Global Neutropenia Biologic Drug Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

7. Neutropenia Biologic Drug Treatment Market Regional And Country Analysis

  • 7.1. Global Neutropenia Biologic Drug Treatment Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Neutropenia Biologic Drug Treatment Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Neutropenia Biologic Drug Treatment Market

  • 8.1. Asia-Pacific Neutropenia Biologic Drug Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Neutropenia Biologic Drug Treatment Market

  • 9.1. China Neutropenia Biologic Drug Treatment Market Overview
  • 9.2. China Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Neutropenia Biologic Drug Treatment Market

  • 10.1. India Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Neutropenia Biologic Drug Treatment Market

  • 11.1. Japan Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Neutropenia Biologic Drug Treatment Market

  • 12.1. Australia Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Neutropenia Biologic Drug Treatment Market

  • 13.1. Indonesia Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Neutropenia Biologic Drug Treatment Market

  • 14.1. South Korea Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Neutropenia Biologic Drug Treatment Market

  • 15.1. Western Europe Neutropenia Biologic Drug Treatment Market Overview
  • 15.2. Western Europe Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Neutropenia Biologic Drug Treatment Market

  • 16.1. UK Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Neutropenia Biologic Drug Treatment Market

  • 17.1. Germany Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Neutropenia Biologic Drug Treatment Market

  • 18.4. France Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Neutropenia Biologic Drug Treatment Market

  • 19.1. Eastern Europe Neutropenia Biologic Drug Treatment Market Overview
  • 19.2. Eastern Europe Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Neutropenia Biologic Drug Treatment Market

  • 20.1. Russia Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Neutropenia Biologic Drug Treatment Market

  • 21.1. North America Neutropenia Biologic Drug Treatment Market Overview
  • 21.2. North America Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Neutropenia Biologic Drug Treatment Market

  • 22.1. USA Neutropenia Biologic Drug Treatment Market Overview
  • 22.2. USA Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Neutropenia Biologic Drug Treatment Market

  • 23.1. South America Neutropenia Biologic Drug Treatment Market Overview
  • 23.2. South America Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Neutropenia Biologic Drug Treatment Market

  • 24.1. Brazil Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Neutropenia Biologic Drug Treatment Market

  • 25.1. Middle East Neutropenia Biologic Drug Treatment Market Overview
  • 25.2. Middle East Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Neutropenia Biologic Drug Treatment Market

  • 26.1. Africa Neutropenia Biologic Drug Treatment Market Overview
  • 26.2. Africa Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Neutropenia Biologic Drug Treatment Market Competitive Landscape And Company Profiles

  • 27.1. Neutropenia Biologic Drug Treatment Market Competitive Landscape
  • 27.2. Neutropenia Biologic Drug Treatment Market Company Profiles
    • 27.2.1. Teva Pharmaceutical
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Amgen
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Sanofi
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Mylan
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Kyowa Kirin
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Neutropenia Biologic Drug Treatment Pipeline Analysis

29. Key Mergers And Acquisitions In The Neutropenia Biologic Drug Treatment Market

30. Neutropenia Biologic Drug Treatment Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer